Adam Gibb, Craig Jones, Adrian Bloor, Samar Kulkarni, Tim Illidge, Kim Linton, John Radford. Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center. Haematologica 2013;98(4):611-614; https://doi.org/10.3324/haematol.2012.069393.